These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 16678934

  • 1. CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease.
    Abdo WF, Bloem BR, Van Geel WJ, Esselink RA, Verbeek MM.
    Neurobiol Aging; 2007 May; 28(5):742-7. PubMed ID: 16678934
    [Abstract] [Full Text] [Related]

  • 2. CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia.
    Abdo WF, van de Warrenburg BP, Munneke M, van Geel WJ, Bloem BR, Kremer HP, Verbeek MM.
    Neurology; 2006 Aug 08; 67(3):474-9. PubMed ID: 16894110
    [Abstract] [Full Text] [Related]

  • 3. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B, Rosengren L, Karlsson JE, Johnels B.
    Mov Disord; 1998 Jan 08; 13(1):70-7. PubMed ID: 9452329
    [Abstract] [Full Text] [Related]

  • 4. Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis.
    Hu X, Yang Y, Gong D.
    Neurol Sci; 2017 Mar 08; 38(3):407-414. PubMed ID: 27896490
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease.
    van Eijk JJ, van Everbroeck B, Abdo WF, Kremer BP, Verbeek MM.
    J Alzheimers Dis; 2010 Mar 08; 21(2):569-76. PubMed ID: 20555148
    [Abstract] [Full Text] [Related]

  • 7. Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders.
    Constantinescu R, Rosengren L, Johnels B, Zetterberg H, Holmberg B.
    Parkinsonism Relat Disord; 2010 Feb 08; 16(2):142-5. PubMed ID: 19647470
    [Abstract] [Full Text] [Related]

  • 8. Serum prolactin levels in Parkinson's disease and multiple system atrophy.
    Winkler AS, Landau S, Chaudhuri KR.
    Clin Auton Res; 2002 Oct 08; 12(5):393-8. PubMed ID: 12420085
    [Abstract] [Full Text] [Related]

  • 9. Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.
    Sako W, Murakami N, Izumi Y, Kaji R.
    J Neurol Sci; 2015 May 15; 352(1-2):84-7. PubMed ID: 25868897
    [Abstract] [Full Text] [Related]

  • 10. CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls.
    Pijnenburg YA, Janssen JC, Schoonenboom NS, Petzold A, Mulder C, Stigbrand T, Norgren N, Heijst H, Hack CE, Scheltens P, Teunissen CE.
    Dement Geriatr Cogn Disord; 2007 May 15; 23(4):225-30. PubMed ID: 17290105
    [Abstract] [Full Text] [Related]

  • 11. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, Koel-Simmelink MJ, Schepens M, Bouwman F, Twaalfhoven HA, Blom HJ, Jakobs C, Dijkstra CD.
    Neurology; 2009 Apr 14; 72(15):1322-9. PubMed ID: 19365053
    [Abstract] [Full Text] [Related]

  • 12. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
    Brettschneider J, Petzold A, Süssmuth SD, Landwehrmeyer GB, Ludolph AC, Kassubek J, Tumani H.
    Mov Disord; 2006 Dec 14; 21(12):2224-7. PubMed ID: 17013909
    [Abstract] [Full Text] [Related]

  • 13. CSF biomarker profiles do not differentiate between the cerebellar and parkinsonian phenotypes of multiple system atrophy.
    Abdo WF, van de Warrenburg BP, Kremer HP, Bloem BR, Verbeek MM.
    Parkinsonism Relat Disord; 2007 Dec 14; 13(8):480-2. PubMed ID: 17448720
    [Abstract] [Full Text] [Related]

  • 14. Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy.
    Holmberg B, Johnels B, Blennow K, Rosengren L.
    Mov Disord; 2003 Feb 14; 18(2):186-90. PubMed ID: 12539213
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT, Pivonello R, Salvatore E, Faggiano A, Barone P, De Michele G, Lombardi G, Colao A, Filla A.
    Clin Endocrinol (Oxf); 2005 Apr 14; 62(4):428-33. PubMed ID: 15807873
    [Abstract] [Full Text] [Related]

  • 16. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G, Lodi R, Condino F, Tonon C, Fera F, Malucelli E, Manners D, Zappia M, Morgante L, Barone P, Barbiroli B, Quattrone A.
    Brain; 2006 Oct 14; 129(Pt 10):2679-87. PubMed ID: 16815875
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease.
    Abdo WF, De Jong D, Hendriks JC, Horstink MW, Kremer BP, Bloem BR, Verbeek MM.
    Mov Disord; 2004 May 14; 19(5):571-9. PubMed ID: 15133823
    [Abstract] [Full Text] [Related]

  • 18. CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls.
    Herbert MK, Eeftens JM, Aerts MB, Esselink RA, Bloem BR, Kuiperij HB, Verbeek MM.
    Parkinsonism Relat Disord; 2014 Jan 14; 20(1):112-5. PubMed ID: 24075122
    [Abstract] [Full Text] [Related]

  • 19. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
    Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P.
    Biol Psychiatry; 2008 Nov 15; 64(10):850-5. PubMed ID: 18395699
    [Abstract] [Full Text] [Related]

  • 20. Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes.
    Bech S, Hjermind LE, Salvesen L, Nielsen JE, Heegaard NH, Jørgensen HL, Rosengren L, Blennow K, Zetterberg H, Winge K.
    Parkinsonism Relat Disord; 2012 Jan 15; 18(1):69-72. PubMed ID: 21873100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.